IP Library Granted Patent US 11,613,555
Granted Patent B2
US 11,613,555 · App. 17/034,598 · Granted Mar 28, 2023

Methods for onapristone synthesis dehydration and deprotection

Inventors: Ulf Tilstam (Hoegaarden, BE); Stefan Proniuk (Austin, TX); Ferry Brands (Berghem, NL)
Assignee: CONTEXT BIOPHARMA, INC.
C07J41/0083C07J21/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,613,555
App. No.
17/034,598
Granted
Mar 28, 2023
Kind
B2
Abstract

Methods and systems for making onapristone (ONA) using acidic hydrolysis and dehydration with sulfuric acid in an alcoholic solution are provided.

Claims (28)

1. A method of making onapristone comprising:

reacting the compound of Formula I:

with sulfuric acid in a solution comprising pyridine and a solvent to deprotect and dehydrate the compound of Formula I;

maintaining the reaction temperature below about 60° C.;

neutralizing the reaction with an inorganic base to form a solution; and

extracting the compound of Formula II

from the solution.

2. The method of claim 1 , wherein the sulfuric acid is diluted up to 80% with water.

3. The method of claim 2 , wherein the sulfuric acid is diluted from 30 to 60% with water.

4. The method of claim 3 , wherein the sulfuric acid is diluted with 50% water.

5. The method of claim 1 , wherein the solvent is selected form the group consisting of methanol, ethanol, acetone, n-propanol and isopropanol.

6. The method of claim 5 , wherein the solvent is methanol.

7. The method of claim 1 , wherein the temperature is maintained between about −50 to about 60° C.

8. The method of claim 7 , wherein the temperature is maintained between about −10 and 30° C.

9. The method of claim 8 , wherein the temperature is maintained from about 0 to about 15° C.

10. The method of claim 1 , wherein the inorganic base is selected from the group consisting of sodium hydrogen carbonate, sodium phosphate or ammonia.

11. The method of claim 10 , wherein the inorganic base is ammonia with a concentration between about 5 and 30%.

12. The method of claim 11 , wherein the inorganic base is 30% ammonia.

13. The method of claim 1 , wherein the reaction with the inorganic base is performed at a temperature from about 0 to about 30° C.

14. The method of claim 13 , wherein the reaction with the inorganic base is performed at a temperature from about 0 to about 15° C.

15. The method of claim 1 , wherein extraction of the compound of Formula II is performed with ethyl acetate.

16. The method of claim 1 , wherein extraction of the compound of Formula II is performed by crystallization.

17. The method of claim 1 , further comprising concentrating the solution.

18. The method of claim 17 , wherein the solution is concentrated by vacuum distillation.

19. The method of claim 1 , wherein the volume ratio of pyridine to the solvent is in a range of about 1:0.001 to about 1:0.03.

20. The method of claim 1 , wherein the method further comprises reacting at least 1 kg of the compound of Formula I.

21. The method of claim 1 , wherein the method provides a yield of about 80%.

22. The method of claim 1 , wherein the method provides onapristone at a purity of about 88.9%.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: PRONIUK, STEFAN; BRANDS, FERRY
To: ARNO THERAPEUTICS, INC.
Reel/Frame 056368/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: ARNO THERAPEUTICS, INC.
To: CONTEXT BIOPHARMA INC
Reel/Frame 056368/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: TILSTAM, ULF
To: ARNO THERAPEUTICS, INC.
Reel/Frame 056370/0398 →
Continuity (3)
Continuation 15825697 · Nov 29, 2017
Provisional Application 62428401 · Nov 30, 2016
Related Publication 20210221838A1 · Jul 22, 2021